Does ARIPIPRAZOLE Cause Psychomotor hyperactivity? 389 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 389 reports of Psychomotor hyperactivity have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.6% of all adverse event reports for ARIPIPRAZOLE.
389
Reports of Psychomotor hyperactivity with ARIPIPRAZOLE
0.6%
of all ARIPIPRAZOLE reports
6
Deaths
187
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From ARIPIPRAZOLE?
Of the 389 reports, 6 (1.5%) resulted in death, 187 (48.1%) required hospitalization, and 22 (5.7%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 389 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Product use in unapproved indication (4,792)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
LORAZEPAM (197)
Which ARIPIPRAZOLE Alternatives Have Lower Psychomotor hyperactivity Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE